急性肺栓塞中D-二聚体与血栓负荷的关系
该回顾性研究分析了161例肺栓塞患者,按临床指征分为5个血栓负荷亚组,比较D-二聚体水平。单变量线性回归显示D-二聚体与组别相关(β 0.050,95%CI 0.002-0.099,P=.043),多变量调整后呈边缘显著(β 0.047,95%CI 0.002-0.096,P=.058)。在129例血压正常患者中,有右心室功能障碍者D-二聚体显著高于无右心室功能障碍者(1.73 vs 1.17 mg/l,P=.049)。ROC曲线AUC为0.61,最佳截断值1.18 mg/l,多变量logistic回归证实D-二聚体>1.18 mg/l与右心室功能障碍相关(OR 2.721,95%CI 1.196-6.190,P=.017)。结论认为血栓负荷与D-二聚体升高相关,D-二聚体>1.18 mg/l可预测血压正常患者的右心室功能障碍,D-二聚体水平受深静脉血栓影响,但不受癌症、肺炎、年龄或肾功能损害影响。
要点
- 在129例血压正常的肺栓塞患者中,合并右心室功能障碍者D-二聚体水平显著高于无右心室功能障碍者(1.73 vs 1.17 mg/l,P=.049)。
- D-二聚体>1.18 mg/l与血压正常肺栓塞患者的右心室功能障碍独立相关(OR 2.721,95%CI 1.196-6.190,P=.017)。
- D-二聚体预测右心室功能障碍的ROC曲线AUC为0.61,最佳截断值为1.18 mg/l。
- D-二聚体水平随血栓负荷组别升高而显著增加(Kruskal-Wallis检验),但多变量调整后关联仅为边缘显著(P=.058)。
- D-二聚体水平受深静脉血栓影响,但不受癌症、肺炎、年龄或肾功能损害影响。
适用人群与场景
- 161例肺栓塞患者,其中女性60.9%,年龄>70岁者54.0%。
- 血压正常的肺栓塞患者129例,用于评估D-二聚体预测右心室功能障碍。
诊断标准与关键阈值
- D-二聚体>1.18 mg/l为预测血压正常肺栓塞患者右心室功能障碍的最佳截断值(ROC曲线计算)。
研究设计与关键结果
- 回顾性分析161例肺栓塞患者,按临床指征分为5个血栓负荷亚组,比较D-二聚体水平。
- 单变量线性回归显示D-二聚体与组别相关(β 0.050,95%CI 0.002-0.099,P=.043);多变量调整年龄、性别、癌症和肺炎后呈边缘显著(β 0.047,95%CI 0.002-0.096,P=.058)。
- Kruskal-Wallis检验显示D-二聚体随组别升高而显著增加。
- 在129例血压正常患者中,有右心室功能障碍者D-二聚体显著高于无右心室功能障碍者(1.73(1.11/3.48)vs 1.17(0.65/2.90)mg/l,P=.049)。
- ROC曲线AUC为0.61,最佳截断值1.18 mg/l;多变量logistic回归显示D-二聚体>1.18 mg/l与右心室功能障碍相关(OR 2.721,95%CI 1.196-6.190,P=.017)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在血压正常的肺栓塞患者中,D-二聚体>1.18 mg/l提示右心室功能障碍风险增加(OR 2.721),但AUC仅0.61,预测效能有限,不能单独作为决策依据。
- D-二聚体水平受深静脉血栓影响,解读时应考虑是否合并深静脉血栓;癌症、肺炎、年龄或肾功能损害不影响D-二聚体与血栓负荷的关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Thrombus burden in pulmonary embolism (PE) is associated with higher D-Dimer-levels and poorer prognosis. We aimed to investigate i) the influence of right ventricular dysfunction (RVD), deep venous thrombosis (DVT), and high-risk PE-status on D-Dimer-levels and ii) effectiveness of D-Dimer to predict RVD in normotensive PE patients.
METHODS: Overall, 161 PE patients were analyzed retrospectively, classified in 5 subgroups of thrombus burden according to clinical indications and compared regarding D-Dimer-levels. Linear regression models were computed to investigate the association between D-Dimer and the groups. In hemodynamically stable PE patients, a ROC curve was calculated to assess the effectiveness of D-Dimer for predicting RVD.
RESULTS: Overall, 161 patients (60.9% females, 54.0% aged >70 years) were included in this analysis. The D-Dimer-level was associated with group-category in a univariate linear regression model (β 0.050 (95%CI 0.002-0.099), P = .043). After adjustment for age, sex, cancer, and pneumonia in a multivariate model we observed an association between D-Dimer and group-category with borderline significance (β 0.047 (95%CI 0.002-0.096), P = .058). The Kruskal-Wallis test demonstrated that D-Dimer increased significantly with higher group-category. In 129 normotensive patients, patients with RVD had significantly higher D-Dimer values compared to those without (1.73 (1.11/3.48) vs 1.17 (0.65/2.90) mg/l, P = .049). A ROC curve showed an AUC of 0.61, gender non-specific, with calculated optimal cut-off of 1.18 mg/l. Multi-variate logistic regression model confirmed an association between D-Dimer >1.18 mg/l and RVD (OR2.721 (95%CI 1.196-6.190), P = .017).
CONCLUSIONS: Thrombus burden in PE is related to elevated D-Dimer levels, and D-Dimer values >1.18 mg/l were predictive for RVD in normotensive patients. D-Dimer levels were influenced by DVT, but not by cancer, pneumonia, age, or renal impairment.
参考来源
- Keller K, Beule J, Balzer JO, et al. D-Dimer and thrombus burden in acute pulmonary embolism. Am J Emerg Med. 2018. PMID: 29371044. doi:10.1016/j.ajem.2018.01.048
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。